IFM Therapeutics

About:

DescriptionIFM Therapeutics is a pharmaceutical company focused on developing biological treatments for autoimmune diseases.

Website: https://www.ifmthera.com/

Twitter/X: ifmthera

Top Investors: Novartis, Atlas Venture, Omega Funds, Abingworth

Description:

IFM Therapeutics is a provider of small molecule that module novel targets in the innate immune system. The company and its academic collaborators combine unparalleled expertise in innate immunity with seasoned drug discovery and development professionals. Its subsidiary IFM Due is focused on the discovery and developing antagonists of the cGAS/STING pathway for the treatment of inflammation, neuroinflammation, autoimmunity and cancer. IFM Discovery, a newly financed incubator entity within the IFM enterprise, is prosecuting a basket of genetically-validated targets as next-generation therapies for inflammation, neuroinflammation, autoimmunity and fibrosis